| Tara Brook Hasenpflug, DO | |
|
9101 S Toledo Ave Ste B, Tulsa, OK 74137-2719 | |
| (918) 392-3444 | |
| (918) 392-3469 |
| Full Name | Tara Brook Hasenpflug |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 9101 S Toledo Ave Ste B, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033400544 | NPI | - | NPPES |
| 200445710A | Medicaid | OK | |
| 359788YLV0 | Other | OK | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5227 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Oklahoma State University Medical Center | Tulsa, OK | Hospital |
| St John Medical Center, Inc | Tulsa, OK | Hospital |
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Entity Name | Ahs Oklahoma Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235182775 PECOS PAC ID: 9436122496 Enrollment ID: O20040817001197 |
News Archive
Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its full year and fourth quarter 2010 results.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
A Vanderbilt University-led research team has identified protein "signatures" of genetic mutations that drive colorectal cancer, the nation's second leading cause of cancer deaths after lung cancer.
University of Warwick researchers have teamed up with Canadian scientists on a -2.2 million project to search for new antibiotics which will beat resistance in deadly "superbugs".
Choline is an essential nutrient that is used by the body in a number of ways. However, nearly 90 percent of adults do not get the recommended amount in their diets.
› Verified 3 days ago
| Entity Name | Osumc Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922325992 PECOS PAC ID: 9234254012 Enrollment ID: O20100916000969 |
News Archive
Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its full year and fourth quarter 2010 results.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
A Vanderbilt University-led research team has identified protein "signatures" of genetic mutations that drive colorectal cancer, the nation's second leading cause of cancer deaths after lung cancer.
University of Warwick researchers have teamed up with Canadian scientists on a -2.2 million project to search for new antibiotics which will beat resistance in deadly "superbugs".
Choline is an essential nutrient that is used by the body in a number of ways. However, nearly 90 percent of adults do not get the recommended amount in their diets.
› Verified 3 days ago
| Entity Name | My Doctor Family Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316629868 PECOS PAC ID: 6800241233 Enrollment ID: O20231004003723 |
News Archive
Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its full year and fourth quarter 2010 results.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
A Vanderbilt University-led research team has identified protein "signatures" of genetic mutations that drive colorectal cancer, the nation's second leading cause of cancer deaths after lung cancer.
University of Warwick researchers have teamed up with Canadian scientists on a -2.2 million project to search for new antibiotics which will beat resistance in deadly "superbugs".
Choline is an essential nutrient that is used by the body in a number of ways. However, nearly 90 percent of adults do not get the recommended amount in their diets.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tara Brook Hasenpflug, DO 9101 S Toledo Ave Ste B, Tulsa, OK 74137-2719 Ph: (918) 392-3444 | Tara Brook Hasenpflug, DO 9101 S Toledo Ave Ste B, Tulsa, OK 74137-2719 Ph: (918) 392-3444 |
News Archive
Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its full year and fourth quarter 2010 results.
According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.
A Vanderbilt University-led research team has identified protein "signatures" of genetic mutations that drive colorectal cancer, the nation's second leading cause of cancer deaths after lung cancer.
University of Warwick researchers have teamed up with Canadian scientists on a -2.2 million project to search for new antibiotics which will beat resistance in deadly "superbugs".
Choline is an essential nutrient that is used by the body in a number of ways. However, nearly 90 percent of adults do not get the recommended amount in their diets.
› Verified 3 days ago
Eric Sandoval, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1111 South St.louis Ave, Tulsa, OK 74120 Phone: 918-619-3395 | |
Dr. Robert Capehart, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1110 E 18th St, Tulsa, OK 74120 Phone: 918-361-2771 | |
Dr. Terence E Grewe, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3316 E 21st St, Suite A, Tulsa, OK 74114 Phone: 918-749-3533 Fax: 918-749-9789 | |
Brian Crotty, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1919 S Wheeling Ave, Ll 100, Tulsa, OK 74104 Phone: 918-748-7890 Fax: 918-403-6300 | |
Charles C Powell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7501 Riverside Pkwy, Tulsa, OK 74136 Phone: 918-710-4200 Fax: 918-403-6331 | |
Jess T Roy, D.O. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 7912 E 31st Ct, Suite 220, Tulsa, OK 74145 Phone: 918-743-8200 Fax: 918-743-8609 | |
Dr. Robert Leroy Winter, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3140 S Lewis Pl, Tulsa, OK 74105 Phone: 918-749-1396 |